42 U.S. lawmakers have disclosed 87 Eli Lilly and Company trades under the STOCK Act — 43 buys and 44 sells between 2013 and 2026. Congress has been net sellers of LLY, and their disclosed buys are up 54.5% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of LLY, marked to the latest close — per-share (share counts aren't disclosed).
1 member disclosed a LLY purchase in the last 90 days (newest first).
Lawmakers ranked by notional-weighted return on their disclosed LLY buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2022-06-30 | Roger Williams | BUY | $1K–$15K | $324.23 | $1209.00 2026-08-13 | +272.9% |
| 2022-01-14 | Thomas H Tuberville | SELL | $15K–$50K | $244.12 | $1209.00 2026-08-13 | -395.3% exit |
| 2020-04-16 | David A Perdue , Jr | SELL | $1K–$15K | $154.73 | $1209.00 2026-08-13 | -681.4% exit |
| 2020-04-16 | David A Perdue , Jr | SELL | $1K–$15K | $154.73 | $1209.00 2026-08-13 | -681.4% exit |
| 2020-04-07 | Kelly Loeffler | BUY | $1K–$15K | $141.88 | $1209.00 2026-08-13 | +752.1% |
| 2020-03-26 | Steve Cohen | SELL | $1K–$15K | $134.35 | $1209.00 2026-08-13 | -799.9% exit |
| 2020-03-13 | Nicholas Van Taylor | SELL | $500K–$1.0M | $139.37 | $1209.00 2026-08-13 | -767.5% exit |
| 2019-08-29 | Steve Cohen | SELL | $1K–$15K | $112.25 | $1209.00 2026-08-13 | -977.1% exit |
| 2019-04-18 | Mikie Sherrill | SELL | $1K–$15K | $115.20 | $1209.00 2026-08-13 | -949.5% exit |
| 2019-02-28 | Alan S. Lowenthal | BUY | $1K–$15K | $126.29 | $1209.00 2026-08-13 | +857.3% |
| 2019-02-28 | Alan S. Lowenthal | BUY | $1K–$15K | $126.29 | $1209.00 2026-08-13 | +857.3% |
| 2019-02-20 | John Rutherford | SELL | $1K–$15K | $122.66 | $1209.00 2026-08-13 | -885.6% exit |
| 2018-08-30 | Zoe Lofgren | SELL | $1K–$15K | $105.48 | $1209.00 2026-08-13 | -1046.2% exit |
| 2018-06-01 | Pete Sessions | SELL | $1K–$15K | $84.85 | $1209.00 2026-08-13 | +11.2% rt |
| 2016-11-02 | Rubén Hinojosa | SELL | $1K–$15K | $72.65 | $1209.00 2026-08-13 | -15.7% rt |
| 2016-09-23 | Bill Flores | SELL | $1K–$15K | $81.16 | $1209.00 2026-08-13 | +14.9% rt |
| 2016-09-19 | Raúl M. Grijalva | SELL | $1K–$15K | $79.16 | $1209.00 2026-08-13 | +8.7% rt |
| 2016-07-22 | Bill Flores | SELL | $1K–$15K | $81.59 | $1209.00 2026-08-13 | +9.3% rt |
| 2016-07-21 | Bill Flores | SELL | $1K–$15K | $80.40 | $1209.00 2026-08-13 | +1.6% rt |
| 2016-07-20 | James B. Renacci | BUY | $1K–$15K | $80.28 | $1209.00 2026-08-13 | +1406.0% |
| 2016-05-19 | Bill Flores | SELL | $1K–$15K | $74.31 | $1209.00 2026-08-13 | -3.5% rt |
| 2016-04-18 | Bill Flores | SELL | $15K–$50K | $77.22 | $1209.00 2026-08-13 | -2.1% rt |
| 2016-03-28 | Bill Flores | BUY | $1K–$15K | $70.62 | $1209.00 2026-08-13 | +1612.0% |
| 2016-03-16 | Ed Whitfield | SELL | $1K–$15K | $72.48 | $1209.00 2026-08-13 | -5.6% rt |
| 2016-02-17 | Bill Flores | BUY | $1K–$15K | $74.68 | $1209.00 2026-08-13 | +1518.9% |
| 2016-02-04 | Ed Whitfield | BUY | $1K–$15K | $74.28 | $1209.00 2026-08-13 | +1527.6% |
| 2016-02-02 | Pete Sessions | BUY | $1K–$15K | $76.30 | $1209.00 2026-08-13 | +1484.5% |
| 2016-01-29 | Bill Flores | BUY | $1K–$15K | $79.10 | $1209.00 2026-08-13 | +1428.5% |
| 2016-01-28 | Ed Whitfield | BUY | $1K–$15K | $76.81 | $1209.00 2026-08-13 | +1474.0% |
| 2016-01-22 | K. Michael Conaway | BUY | $1K–$15K | $82.48 | $1209.00 2026-08-13 | +1365.8% |
| 2015-12-23 | Rubén Hinojosa | BUY | $1K–$15K | $86.20 | $1209.00 2026-08-13 | +1302.5% |
| 2015-11-18 | Katherine M. Clark | SELL | $15K–$50K | $83.65 | $1209.00 2026-08-13 | -1345.3% exit |
| 2015-10-21 | Bill Flores | BUY | $1K–$15K | $77.01 | $1209.00 2026-08-13 | +1469.9% |
| 2015-07-01 | James B. Renacci | SELL | $1K–$15K | $84.85 | $1209.00 2026-08-13 | -1324.9% exit |
| 2015-05-29 | Bill Flores | BUY | $1K–$15K | $78.90 | $1209.00 2026-08-13 | +1432.3% |
| 2015-05-13 | Raúl M. Grijalva | BUY | $1K–$15K | $72.80 | $1209.00 2026-08-13 | +1560.7% |
| 2013-01-14 | SUSAN M COLLINS | SELL | $1K–$15K | $52.80 | $1209.00 2026-08-13 | -2189.8% exit |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
42 members of the U.S. House and Senate have disclosed Eli Lilly and Company transactions under the STOCK Act — 43 purchases and 44 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
1 member disclosed a LLY purchase in the last 90 days — most recently Gilbert Cisneros on 2026-06-10. See the "Lawmakers who bought LLY recently" section above for the dated list.
Notional-weighted, lawmakers' disclosed LLY buys are up 54.5% versus the latest close of $1209.00. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded LLY and how it performed.